NeuroPace, Inc. (NPCE) vs Sight Sciences, Inc. (SGHT)
NeuroPace, Inc. and Sight Sciences, Inc. are both Medical Devices companies. NeuroPace, Inc. and Sight Sciences, Inc. are of similar size ($479.5M and $478.2M). NeuroPace, Inc. grew revenue faster over the last twelve months: 21.7% against 9.27%. NeuroPace, Inc. has the higher net margin (−18.6% vs −35.7%) and the higher return on invested capital (−44.6% vs −125.2%). Across the 18 metrics below, NeuroPace, Inc. leads on 12 and Sight Sciences, Inc. on 6.
Valuation
Profitability
| Metric | NPCE | SGHT | Medical Devices median |
|---|---|---|---|
| Gross margin | 78.38% | 87.96% | 56.01% |
| Operating margin | (13.33%) | (33.43%) | (15.03%) |
| Net margin | (18.58%) | (35.69%) | (20.40%) |
| Free cash flow margin | (11.29%) | (27.98%) | (7.24%) |
| Return on equity | (122.05%) | (48.42%) | (15.32%) |
| Return on assets | (18.82%) | (26.24%) | (19.72%) |
| Return on invested capital | (44.64%) | (125.18%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack